Minocycline-induced dermatomyositis

Muscle and Nerve

Volumn 41, Issue 4, 2010, Pages 547-549

  Geddes, Maiya R ^a   Sinnreich, Michael ^a   Chalk, Colin ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Case report; Dermatomyositis; Drug induced; Minocycline; Myopathy

Indexed keywords

METHOTREXATE; MINOCYCLINE; PREDNISONE;

ACNE VULGARIS; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DERMATOMYOSITIS; DISEASE COURSE; DRUG WITHDRAWAL; ERYTHEMA NODOSUM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PANNICULITIS; PRIORITY JOURNAL; SKIN BIOPSY; TREATMENT OUTCOME;

DERMATOMYOSITIS; FEMALE; HUMANS; MINOCYCLINE; YOUNG ADULT;

EID: 77950249806     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21487     Document Type: Article

References (14)

1. Elkayam O, Yaron M, Caspi D. Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum 1999;28:392-397.
2. Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM. The promise of minocycline in neurology. Lancet 2004;3:744-751.
3. Narvaez J, Vilaseca-Momplet Narvaez J. Severe acute myopathy induced by minocycline. Am J Med 2004;116:282-283.
4. Rahman Z, Weinberg J, Scheinfeld N. Minocycline hypersensitivity syndrome manifesting with rhabdomyolysis. Int J Dermatol 2002;41:525-531.
5. World Health Organization. Causality assessment of suspected adverse reactions. Available from: URL: www.who-umc.org/DynPage.aspx?id=22682 Accessed March 2009.
6. Dalakas MC. Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies. Nat Clin Prac Rheum 2006;2:219-227.
7. Magro CM, Schaefer JT, Waldman J, Knight D, Seilstad K, Hearne D. Terbinafine-induced dermatomyositis: a case report and literature review of drug-induced dermatomyositis. J Cutan Pathol 2008;35:74-81.
8. Seidler Am, Gottlieb AB. Dermatomyositis induced by drug therapy: a review of case reports. J Am Acad Dermatol 2008;59:872-880.
9. Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist 2005;11:308-322.
10. Aleska M, Szegedi A, Antal-Szalmas P, Irinyi B, Gergely L, Ponyi A, et al. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis. Ann Rheum Dis 2005;64: 1485-1489.
11. Ishii W, Matsuda M, Shimojima Y, Itoh S, Sumida T, Ikeda S. Flow cytometric analysis of lymphocyte subpopulations and th1/th2 balance in patients with polymyositis and dermatomyositis. Intern Med 2008;47:1593-1599.
12. Goldmann M, Druet P, Gleichmann E. Th2 cells in systemic autoimmunity: insights from allogenic diseases and chemically-induced autoimmunity. Immunol Today 1991;12:223-227.
13. Noel B. Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J Eur Acad Dermatol Venereol 2007;21:17-24.
14. Giuliani F, Metz LM, Wilson T, Fan Y, Bar-Or A, Yong W. Additive effect of the combination of glatiramer acetate and minocycline in a model of MS. J Neuroimmunol 2005;158:213-221.